George Budwell
George Budwell, Ph.D., is a contributing Biotechnology and Technology Analyst at The Motley Fool, covering disruptive innovators in healthcare, defense, and artificial intelligence, and writing on portfolio theory, dividend stocks, and value investing. Prior to The Motley Fool, George was a freelance medical and science writer for various organizations, as well as an independent consultant for multiple life sciences-oriented hedge funds. In a former life, he was an evolutionary biologist, having completed two postdoctoral fellowships at Kyoto University and Illinois State University, respectively. He holds a Ph.D. in Evolutionary Biology from Tulane University and a B.S. (pre-med) from Loyola University. Fun fact: George is an avid golfer, nature enthusiast, and proud father of four.
Recent Articles by George Budwell

Is $20 in Sight for Archer Aviation Stock This Year?

2 Elite Dividend Growth Stocks I'm Buying on the Dip

3 Quantum Computing Stocks I'm Buying on the Dip

Is Vertex Pharmaceuticals Stock a Buy in 2025?

How I'm Building My Quantum Computing Portfolio

5 AI Stocks to Load Up On in 2025

3 Incredible Dividend Growth Stocks to Buy Right Now
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.